Literature DB >> 2165081

Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design.

S C Ebert1, W A Craig.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2165081     DOI: 10.1086/646178

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  16 in total

1.  Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.

Authors:  M L Peterson; L B Hovde; D H Wright; G H Brown; A D Hoang; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Activity of once-daily cefpodoxime regimens against Haemophilus influenzae and Streptococcus pneumoniae with an in vitro pharmacodynamic chamber model.

Authors:  M W Garrison; C L Malone; J E Eiland
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  Choosing between the new cephalosporin antibiotics: a pharmacodynamic approach.

Authors:  D P Nicolau; R Quintiliani
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

4.  In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.

Authors:  B J McGrath; C R Marchbanks; D Gilbert; M N Dudley
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Assessment of the use of cefixime for switch therapy.

Authors:  D E Low
Journal:  Infection       Date:  1995       Impact factor: 3.553

6.  Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.

Authors:  D P Nicolau; C H Nightingale; M A Banevicius; Q Fu; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 7.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

8.  Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.

Authors:  R E Lewis; B C Lund; M E Klepser; E J Ernst; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 9.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.

Authors:  Vincent H Tam; Peggy S McKinnon; Ronda L Akins; George L Drusano; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.